GSK purchases Wyeth's vaccine facility
Britiain's largest drugsmaker, GlaxoSmithKline, announced it is to expand its ability to increase vaccines supplies by acquiring a vaccine research and production facility from rivals Wyeth.
Britiain's largest drugsmaker, GlaxoSmithKline, announced it is to expand its ability to increase vaccines supplies by acquiring a vaccine research and production facility from rivals Wyeth.
US researchers have pinpointed a key molecule involved in triggering rare but usually fatal cancers known as rhabdoid tumours. This discovery could lead to novel therapies for these tumours that mainly affect children.
New techniques aimed at directly controlling the expression of genes by activating or inactivating them at the DNA level could lead to drugs for the treatment or cure of almost any disease, say researchers
Scentists have employed a new technique to manipulate the sugars that power many front-line drugs, which has resulted in the enhancement of a drug for heart disease. Manipulating the natural sugars in a drug could help make natural products more...